{"id":"NCT03030599","sponsor":"Jazz Pharmaceuticals","briefTitle":"A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy","officialTitle":"A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-03-14","primaryCompletion":"2019-01-24","completion":"2019-07-10","firstPosted":"2017-01-25","resultsPosted":"2020-11-12","lastUpdate":"2020-11-12"},"enrollment":201,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Narcolepsy With Cataplexy"],"interventions":[{"type":"DRUG","name":"JZP-258","otherNames":["XyremÂ®"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"JZP-258","type":"EXPERIMENTAL"}],"summary":"This is a double-blind, placebo-controlled, randomized-withdrawal, multicenter study of the efficacy and safety of JZP-258.","primaryOutcome":{"measure":"Change in Weekly Number of Cataplexy Attacks","timeFrame":"Change from baseline (2 weeks of the Stable Dose Period) to the 2 weeks of the Double Blind Randomized Withdrawal Period (DB RWP)","effectByArm":[{"arm":"JZP-258","deltaMin":0,"sd":null},{"arm":"Placebo","deltaMin":2.35,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":25,"countries":["United States","Belgium","Czechia","Finland","France","Spain"]},"refs":{"pmids":["36947322","35635687","33184650"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":201},"commonTop":["Headache","Nausea","Cataplexy","Dizziness","Nasopharyngitis"]}}